FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000987923> ?p ?o ?g. }

• W2000987923 abstract "Background Sepsis is a common and frequently fatal condition. Human recombinant activated protein C (APC) has been used to reduce the high rate of death by severe sepsis or septic shock. This is an update of a Cochrane review (originally published in 2007 and updated in 2008). Objectives We assessed the clinical effectiveness and safety of APC for the treatment of patients with severe sepsis or septic shock. Search methods For this updated review we searched CENTRAL (The Cochrane Library 2010, Issue 6); MEDLINE (1966 to June 2010); EMBASE (1980 to July 1, 2010); BIOSIS (1965 to July 1, 2010); CINAHL (1982 to 16 June 2010) and LILACS (1982 to 16 June 2010). There was no language restriction. Selection criteria We included randomized controlled trials (RCTs) assessing the effects of APC for severe sepsis in adults and children. We excluded studies on neonates. We considered all‐cause mortality at day 28, at the end of study follow up, and hospital mortality as the primary outcomes. Data collection and analysis We independently performed study selection, risk of bias assessment and data extraction. We estimated relative risks (RR) for dichotomous outcomes. We measured statistical heterogeneity using the I2 statistic. We used a random‐effects model. Main results We identified one new RCT in this update. We included a total of five RCTs involving 5101 participants. For 28‐day mortality, APC did not reduce the risk of death in adult participants with severe sepsis (pooled RR 0.97, 95% confidence interval (CI) 0.78 to 1.22; P = 0.82, I2 = 68%). APC use was associated with an increased risk of bleeding (RR 1.47, 95% CI 1.09 to 2.00; P = 0.01, I2 = 0%). In paediatric patients, APC did not reduce the risk of death (RR 0.98, 95% CI 0.66 to 1.46; P = 0.93). Although the included trials had no major limitations most of them modified their original completion or recruitment protocols. Authors' conclusions This updated review found no evidence suggesting that APC should be used for treating patients with severe sepsis or septic shock. Additionally, APC is associated with a higher risk of bleeding. Unless additional RCTs provide evidence of a treatment effect, policy‐makers, clinicians and academics should not promote the use of APC. Warning: On October 25th 2011, the European Medicines Agency issued a press release on the worldwide withdrawal of Xigris (activated protein C / drotrecogin alfa) from the market by Eli Lilly due to lack of beneficial effect on 28‐day mortality in the PROWESS‐SHOCK study. Furthermore, Eli Lily has announced the discontinuation of all other ongoing clinical trials. The final results of the PROWESS‐SHOCK study are expected to be published in 2012. This systematic review will be updated when results of the PROWESS‐SHOCK or other trials are published." @default.
• W2000987923 created "2016-06-24" @default.
• W2000987923 creator A5028812462 @default.
• W2000987923 creator A5054278670 @default.
• W2000987923 creator A5057758833 @default.
• W2000987923 creator A5071235015 @default.
• W2000987923 date "2012-03-14" @default.
• W2000987923 modified "2023-10-15" @default.
• W2000987923 title "Human recombinant activated protein C for severe sepsis" @default.
• W2000987923 cites W1480232597 @default.
• W2000987923 cites W1488314371 @default.
• W2000987923 cites W1501809547 @default.
• W2000987923 cites W1598602811 @default.
• W2000987923 cites W1602148448 @default.
• W2000987923 cites W1634577593 @default.
• W2000987923 cites W1685198220 @default.
• W2000987923 cites W169029477 @default.
• W2000987923 cites W1706784130 @default.
• W2000987923 cites W1792093655 @default.
• W2000987923 cites W1815640380 @default.
• W2000987923 cites W1850156223 @default.
• W2000987923 cites W1856983313 @default.
• W2000987923 cites W1965764984 @default.
• W2000987923 cites W1965866624 @default.
• W2000987923 cites W1966076267 @default.
• W2000987923 cites W1967992144 @default.
• W2000987923 cites W1968021122 @default.
• W2000987923 cites W1969228974 @default.
• W2000987923 cites W1969287567 @default.
• W2000987923 cites W1970511728 @default.
• W2000987923 cites W1972371513 @default.
• W2000987923 cites W1979445000 @default.
• W2000987923 cites W1980233581 @default.
• W2000987923 cites W1981243375 @default.
• W2000987923 cites W1981680557 @default.
• W2000987923 cites W1982149026 @default.
• W2000987923 cites W1982302677 @default.
• W2000987923 cites W1983198622 @default.
• W2000987923 cites W1983864356 @default.
• W2000987923 cites W1984295371 @default.
• W2000987923 cites W1984304831 @default.
• W2000987923 cites W1989180870 @default.
• W2000987923 cites W1991307730 @default.
• W2000987923 cites W1996659057 @default.
• W2000987923 cites W2000321839 @default.
• W2000987923 cites W2002078344 @default.
• W2000987923 cites W2008793028 @default.
• W2000987923 cites W2009326492 @default.
• W2000987923 cites W2010149513 @default.
• W2000987923 cites W2010275186 @default.
• W2000987923 cites W2011042500 @default.
• W2000987923 cites W2012390102 @default.
• W2000987923 cites W2014579166 @default.
• W2000987923 cites W2016300030 @default.
• W2000987923 cites W2017165658 @default.
• W2000987923 cites W2020363094 @default.
• W2000987923 cites W2023001219 @default.
• W2000987923 cites W2024358287 @default.
• W2000987923 cites W2024414752 @default.
• W2000987923 cites W2025138639 @default.
• W2000987923 cites W2025893393 @default.
• W2000987923 cites W2026170842 @default.
• W2000987923 cites W2026216991 @default.
• W2000987923 cites W2026841215 @default.
• W2000987923 cites W2027065937 @default.
• W2000987923 cites W2031323861 @default.
• W2000987923 cites W2032947392 @default.
• W2000987923 cites W2033557930 @default.
• W2000987923 cites W2034599479 @default.
• W2000987923 cites W2036333900 @default.
• W2000987923 cites W2036541269 @default.
• W2000987923 cites W2037296336 @default.
• W2000987923 cites W2037533969 @default.
• W2000987923 cites W2038436941 @default.
• W2000987923 cites W2040541646 @default.
• W2000987923 cites W2040798867 @default.
• W2000987923 cites W2042672170 @default.
• W2000987923 cites W2044220565 @default.
• W2000987923 cites W2046144957 @default.
• W2000987923 cites W2049057708 @default.
• W2000987923 cites W2049927822 @default.
• W2000987923 cites W2051495768 @default.
• W2000987923 cites W2051703737 @default.
• W2000987923 cites W2052426921 @default.
• W2000987923 cites W2058113350 @default.
• W2000987923 cites W2067681194 @default.
• W2000987923 cites W2070946600 @default.
• W2000987923 cites W2072798059 @default.
• W2000987923 cites W2075425755 @default.
• W2000987923 cites W2076590961 @default.
• W2000987923 cites W2077949180 @default.
• W2000987923 cites W2081269041 @default.
• W2000987923 cites W2082747834 @default.
• W2000987923 cites W2084735257 @default.
• W2000987923 cites W2086552855 @default.
• W2000987923 cites W2087313665 @default.
• W2000987923 cites W2088111085 @default.
• W2000987923 cites W2090132603 @default.
• W2000987923 cites W2093043874 @default.
• W2000987923 cites W2095304697 @default.

• next